{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:38:29Z","timestamp":1789231109477,"version":"build-2803163510"},"reference-count":72,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is now recognized as the most common chronic liver disease worldwide, along with the concurrent epidemics of metabolic syndrome and obesity. Patients with NAFLD have increased risks of end-stage liver disease, hepatocellular carcinoma, and liver-related mortality. However, the largest cause of death among patients with NAFLD is cardiovascular disease followed by extrahepatic malignancies, whereas liver-related mortality is only the third cause of death. Extrahepatic complications of NAFLD include chronic kidney disease, extrahepatic malignancies (such as colorectal cancer), psychological dysfunction, gastroesophageal reflux disease, obstructive sleep apnea syndrome, periodontitis, hypothyroidism, growth hormone deficiency, and polycystic ovarian syndrome. The objective of this narrative review was to summarize recent evidences about extrahepatic complications of NAFLD, with focus on the prevalent\/incident risk of such diseases in patients with NAFLD. To date, an appropriate screening method for extrahepatic complications has not yet been determined. Collaborative care with respective experts seems to be necessary for patient management because extrahepatic complications can occur across multiple organs. Further studies are needed to reveal risk profiles at baseline and to determine an appropriate screening method for extrahepatic diseases.<\/jats:p>","DOI":"10.3390\/diagnostics10110912","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T19:03:37Z","timestamp":1604862217000},"page":"912","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs"],"prefix":"10.3390","volume":"10","author":[{"given":"Wataru","family":"Tomeno","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1931-6326","authenticated-orcid":false,"given":"Kento","family":"Imajo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ebisawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Seita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneyuki","family":"Takimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanami","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7240-4851","authenticated-orcid":false,"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Nogami","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-5462","authenticated-orcid":false,"given":"Yasushi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kirikoshi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, International University of Health and Welfare Atami Hospital, 13-1 Higashikaigancho, Atami-shi, Shizuoka 413-0012, Japan"},{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-9623","authenticated-orcid":false,"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-1436","authenticated-orcid":false,"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2018). CME Exam 3: Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology, 155, e18.","DOI":"10.1053\/j.gastro.2018.11.027"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fendo.2014.00164","article-title":"Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments","volume":"5","author":"Sasaki","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with tpe-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1023\/A:1005661516165","article-title":"Fatty Infiltration of Liver in Hyperlipidemic Patients","volume":"45","author":"Assy","year":"2000","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.atherosclerosis.2008.12.012","article-title":"Elevetad alanine aminotransferase levels predict mortality fron cardiovascular disease and diabetes in Koreans","volume":"205","author":"Yun","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatohepatitis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metabolism"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000343885","article-title":"Association between Nonalcoholic Liver Disease and Chronic Kidney Disease: An Ultrasound Analysis from NHANES 1988\u20131994","volume":"36","author":"Sirota","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jhep.2017.08.024","article-title":"Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study","volume":"67","author":"Sinn","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.12964","article-title":"Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disaease: A propensity-matched cohort study","volume":"286","author":"Park","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","article-title":"Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men","volume":"57","author":"Chang","year":"2008","journal-title":"Metabolism"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2007","journal-title":"Diabetologia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging Liver\u2013Kidney Interactions in Nonalcoholic Fatty Liver Disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2016","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.06.004","article-title":"Assoiation between nonalcoholic fatty liver disease and colorectal tumors in asymptomatic adults undergoing screening colonoscopy: A systematic review and meta-analysis","volume":"87","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2011.237974","article-title":"High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2796.2011.02377.x","article-title":"Nonalcoholic fatty liver disease: An independent risk factor for colorectal neoplasia","volume":"270","author":"Stadlmayr","year":"2011","journal-title":"J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1756283X11402118","article-title":"Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease","volume":"4","author":"Touzin","year":"2011","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1440-1746.2011.06816.x","article-title":"Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: A retrospective cohort study","volume":"27","author":"Lee","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/codi.12172","article-title":"Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy","volume":"15","author":"Huang","year":"2013","journal-title":"Colorectal Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/apt.13866","article-title":"Non-alcoholic fatty liver diseases and risk of colorectal neoplasia","volume":"45","author":"Ahn","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000502684","article-title":"Increased Prevalence of Colorectal Adenomas in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study","volume":"38","author":"Blackett","year":"2019","journal-title":"Dig. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/cas.12241","article-title":"Diabetes mellitus and cancer risk: Pooled analysis of eight cohort studies in Japan","volume":"104","author":"Sasazuki","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/1055-9965.EPI-07-0708","article-title":"Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events","volume":"16","author":"Moghaddam","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Sanna, C., Rosso, C., Marietti, M., and Bugianesi, E. (2016). Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050717"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","volume":"68","author":"Kim","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e000295","DOI":"10.1136\/bmjgast-2019-000295","article-title":"Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: A population-based longitudinal study","volume":"6","author":"Hamaguchi","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","article-title":"The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity \u2013 A longitudinal cohort study","volume":"71","author":"Allen","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11739-017-1774-x","article-title":"Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey","volume":"13","author":"Chang","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01288-6","article-title":"Association between nonalcoholic fatty liver disease and extrahepatic cancers: A systematic review and meta-analysis","volume":"19","author":"Liu","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/mpr.139","article-title":"The economic burden of depression and the cost-effectiveness of treatment","volume":"12","author":"Wang","year":"2003","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: Results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psym.2010.12.019","article-title":"Depression in Patients with Nonalcoholic Fatty Liver Disease and Chronic Viral Hepatitis B and C","volume":"52","author":"Weinstein","year":"2011","journal-title":"J. Psychosom. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jgh.12897","article-title":"Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy","volume":"30","author":"Tomeno","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_42","first-page":"1","article-title":"Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease","volume":"2018","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Colognesi, M., Gabbia, D., and De Martin, S. (2020). Depression and Cognitive Impairment\u2014Extrahepatic Manifestations of NAFLD and NASH. Biomedcine, 8.","DOI":"10.3390\/biomedicines8070229"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/00365520500535402","article-title":"Anthropometric correlates of intragastric pressure","volume":"41","author":"Tran","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000341418","article-title":"High prevelance of gastroesophageal reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity","volume":"86","author":"Fujikawa","year":"2012","journal-title":"Digestion"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.dld.2012.08.005","article-title":"Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux sumptoms","volume":"44","author":"Miele","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cgh.2009.03.007","article-title":"A Population-Based Study Showing an Association Between Gastroesophageal Reflux Disease and Sleep Problems","volume":"7","author":"Jansson","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00535-013-0871-5","article-title":"The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease","volume":"49","author":"Taketani","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1210\/jc.2004-1003","article-title":"Leptin Levels Are Dependent on Sleep Duration: Relationships with Sympathovagal Balance, Carbohydrate Regulation, Cortisol, and Thyrotropin","volume":"89","author":"Spiegel","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/jc.2009-2430","article-title":"A Single Night of Partial Sleep Deprivation Induces Insulin Resistance in Multiple Metabolic Pathways in Healthy Subjects","volume":"95","author":"Donga","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.metabol.2016.05.004","article-title":"Nonalcoholic fatty liver disease and obstructive sleep apnea","volume":"65","author":"Clement","year":"2016","journal-title":"Metabolism"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cld.2019.01.001","article-title":"Obstructive Sleep Apnea and the Liver","volume":"23","author":"Parikh","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9343(02)01570-X","article-title":"Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients","volume":"114","author":"Chin","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000170785","article-title":"Continuous Positive Airway Pressure and Liver Enzymes in Obstructive Sleep Apnoea: Data from a Randomized Controlled Trial","volume":"78","author":"Kohler","year":"2009","journal-title":"Respiration"},{"key":"ref_56","first-page":"378","article-title":"Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials","volume":"21","author":"Tamisier","year":"2015","journal-title":"Respirology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01798.x","article-title":"Relationship between periodontal infections and systemic disease","volume":"13","author":"Seymour","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-011-2342-y","article-title":"Periodontitis and diabetes: A two-way relationship","volume":"55","author":"Preshaw","year":"2012","journal-title":"Diabetologia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1007\/s00784-018-2726-1","article-title":"The potential association between periodontitis and non-alcoholic fatty liver disease: A systematic review","volume":"22","author":"Alakhali","year":"2018","journal-title":"Clin. Oral Investig."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Yoneda, M., Naka, S., Nakano, K., Wada, K., Endo, H., Mawatari, H., Imajo, K., Nomura, R., Hokamura, K., and Ono, M. (2012). Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol., 12.","DOI":"10.1186\/1471-230X-12-16"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of Hypothyroidism in Nonalcoholic Fatty Liver Disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Takahashi, Y. (2017). The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071447"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/apt.14058","article-title":"Polycystic ovary sundrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: An update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod. Health"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e000352","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/dme.13565","article-title":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas","volume":"35","author":"Sberna","year":"2018","journal-title":"Diabet. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"50","author":"Watanabe","year":"2015","journal-title":"J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1517\/14728214.2013.811232","article-title":"Emerging drugs for non-alcoholic steatohepatitis","volume":"18","author":"Tomeno","year":"2013","journal-title":"Expert Opin. Emerg. Drugs"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/11\/912\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:30:39Z","timestamp":1760178639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/11\/912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["diagnostics10110912"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10110912","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]}}}